CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS

被引：21
|
作者：
Martínez-Yélamos, A
Rovira, A
Sánchez-Valle, R
Martínez-Yélamos, S
Tintoré, M
Blanco, Y
Graus, F
Montalban, X
Arbizu, T
Saiz, A
机构：
[1] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Serv Neurol, Barcelona 08036, Spain
[2] Ciutat Sanitaria Univ Bellvitge, Serv Neurol, Lhospitalet De Llobregat, Spain
[3] Hosp Univ Vall Hebron, Clin Neuroimmunol Unit, Barcelona, Spain
来源：
JOURNAL OF NEUROLOGY | 2004年 / 251卷 / 10期
关键词：
D O I：
10.1007/s00415-004-0524-y
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1278 / 1279
页数：2
相关论文
共 50 条
  • [31] Detection of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease Patients Using a New Automated Capillary Western Assay
    A. Fourier
    A. Dorey
    A. Perret-Liaudet
    I. Quadrio
    Molecular Neurobiology, 2018, 55 : 3537 - 3545
  • [32] Duration between initial manifestation of CJD and detection of PSD, specific findings on MRI, CSF 14-3-3 protein, or CSF high NSE
    Sodeyama, N
    Nakamura, Y
    Yamada, M
    Satoh, T
    Kitamoto, T
    Mizusawa, H
    Prions: Food and Drug Safety, 2005, : 235 - 236
  • [33] Role of MRI in prognostic prediction of clinically isolated syndrome in Japanese patients
    Yano, H.
    Katada, F.
    Sato, S.
    Shibayama, H.
    Fukutake, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E14 - E14
  • [34] 20 year MRI and clinical follow-up of patients with clinically isolated syndromes suggestive of MS
    Fisniku, Leonora K.
    Brex, Peter
    Dan, Altmann R.
    Miszkiel, Katherine A.
    Thompson, Alan
    Miller, David
    NEUROLOGY, 2007, 68 (12) : A331 - A331
  • [35] Negative CSF 14-3-3 protein in familial Creutzfeldt-Jakob disease
    Pijnenburg, Y
    Barkhof, F
    Kamphorst, W
    Stam, K
    Scheltens, P
    van Gool, P
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S67 - S67
  • [36] Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease
    Rosenmann, H
    Meiner, Z
    Kahana, E
    Halimi, M
    Lenetsky, E
    Abramsky, O
    Gabizon, R
    NEUROLOGY, 1997, 49 (02) : 593 - 595
  • [37] Monitoring 14-3-3 protein interactions with a homogeneous, fluorescence polarization assay
    Du, YH
    Masters, SC
    Khuri, FR
    Fu, H
    JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (03) : 269 - 276
  • [38] Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome suggestive of MS
    Comi, G.
    Filippi, M.
    JOURNAL OF NEUROLOGY, 2008, 255 : 10 - 10
  • [39] An enzyme-linked immunosorbent assay for the detection of 14-3-3 protein in the cerebrospinal fluid of clinically suspected Creutzfeldt-Jakob disease patients.
    Kenney, KL
    Brechtel, C
    Takahnshi, H
    Kurohara, K
    Anderson, DP
    Gibbs, CJ
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 452 - 452
  • [40] Diffusion-weighted MRI in Creutzfeldt-Jakob disease: A better diagnostic marker than CSF protein 14-3-3?
    Mendez, OE
    Shang, JZ
    Jungreis, CA
    Kaufer, DI
    JOURNAL OF NEUROIMAGING, 2003, 13 (02) : 147 - 151
12345